|
Neoplasia
Citations 371-380 of 4217 total displayed.
|
Past content
(since Jan 1997):
|
Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas
- B. Belinda Ding, J. Jessica Yu, Raymond Y.-L. Yu, Lourdes M. Mendez, Rita Shaknovich, Yonghui Zhang, Giorgio Cattoretti, and B. Hilda Ye
Blood 2008; 111: 1515-1523.
[Abstract]
[Full text]
[PDF]
Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis
- Fiona Murray, Nikos Darzentas, Anastasia Hadzidimitriou, Gerard Tobin, Myriam Boudjogra, Cristina Scielzo, Nikolaos Laoutaris, Karin Karlsson, Fanny Baran-Marzsak, Athanasios Tsaftaris, Carol Moreno, Achilles Anagnostopoulos, Federico Caligaris-Cappio, Dominique Vaur, Christos Ouzounis, Chrysoula Belessi, Paolo Ghia, Fred Davi, Richard Rosenquist, and Kostas Stamatopoulos
Blood 2008; 111: 1524-1533.
[Abstract]
[Full text]
[PDF]
Chromosomal lesions and uniparental disomy detected by SNP arrays in MDS, MDS/MPD, and MDS-derived AML
- Lukasz P. Gondek, Ramon Tiu, Christine L. O'Keefe, Mikkael A. Sekeres, Karl S. Theil, and Jaroslaw P. Maciejewski
Blood 2008; 111: 1534-1542.
[Abstract]
[Full text]
[PDF]
Cbfβ-SMMHC impairs differentiation of common lymphoid progenitors and reveals an essential role for RUNX in early B-cell development
- Ya-Huei Kuo, Rachel M. Gerstein, and Lucio H. Castilla
Blood 2008; 111: 1543-1551.
[Abstract]
[Full text]
[PDF]
FLT3 D835/I836 mutations are associated with poor disease-free survival and a distinct gene-expression signature among younger adults with de novo cytogenetically normal acute myeloid leukemia lacking FLT3 internal tandem duplications
- Susan P. Whitman, Amy S. Ruppert, Michael D. Radmacher, Krzysztof Mrózek, Peter Paschka, Christian Langer, Claudia D. Baldus, Jing Wen, Frederick Racke, Bayard L. Powell, Jonathan E. Kolitz, Richard A. Larson, Michael A. Caligiuri, Guido Marcucci, and Clara D. Bloomfield
Blood 2008; 111: 1552-1559.
[Abstract]
[Full text]
[PDF]
Prognostic factors in childhood anaplastic large cell lymphoma: results of a large European intergroup study
- Marie-Cécile Le Deley, Alfred Reiter, Denise Williams, Georges Delsol, Ilske Oschlies, Keith McCarthy, Martin Zimmermann, and Laurence Brugières, on behalf of the European Intergroup for Childhood Non-Hodgkin Lymphoma
Blood 2008; 111: 1560-1566.
[Abstract]
[Full text]
[PDF]
FLT3-ITD cooperates with inv(16) to promote progression to acute myeloid leukemia
- Hyung-Gyoon Kim, Kyoko Kojima, C. Scott Swindle, Claudiu V. Cotta, Yongliang Huo, Vishnu Reddy, and Christopher A. Klug
Blood 2008; 111: 1567-1574.
[Abstract]
[Full text]
[PDF]
Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study
- Erik Forestier, Shai Izraeli, Berna Beverloo, Oskar Haas, Andrea Pession, Kyra Michalová, Batia Stark, Christine J. Harrison, Andrea Teigler-Schlegel, and Bertil Johansson
Blood 2008; 111: 1575-1583.
[Abstract]
[Full text]
[PDF]
Comprehensive biomarker and genomic analysis identifies p53 status as the major determinant of response to MDM2 inhibitors in chronic lymphocytic leukemia
- Chris Saddler, Peter Ouillette, Lisa Kujawski, Sanjeev Shangary, Moshe Talpaz, Mark Kaminski, Harry Erba, Kerby Shedden, Shaomeng Wang, and Sami N. Malek
Blood 2008; 111: 1584-1593.
[Abstract]
[Full text]
[PDF]
Mediation of apoptosis by and antitumor activity of lumiliximab in chronic lymphocytic leukemia cells and CD23+ lymphoma cell lines
- Nuzhat I. Pathan, Peter Chu, Kandasamy Hariharan, Carolyn Cheney, Arturo Molina, and John Byrd
Blood 2008; 111: 1594-1602.
[Abstract]
[Full text]
[PDF]
|
|
